Valuation (17%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -11.52 | 23.45 |
| PEG Ratio (TTM) | -0.26 | 2.73 |
| P/S Ratio (TTM) | 2.46 | 7.25 |
| P/B Ratio (TTM) | 2.72 | 7.41 |
| P/FCF Ratio (TTM) | -3.09 | 35.20 |
| Price to 5YR AVG Earnings Ratio | N/A | 36.45 |
| Price to 5YR AVG FCF Ratio | N/A | 45.34 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -12.70% | 19.70% |
| ROE (TTM) | -21.67% | 28.28% |
| Net Profit Margin (TTM) | -21.74% | 4.65% |
| ROIC 5YR AVG | N/A | 24.77% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 15.52% | -106.19% | N/A |
| Revenue | -7.86% | 43.47% | N/A |
| Net Income | 15.49% | -124.44% | N/A |
| Cash Flow | -20.45% | -284,868.88% | N/A |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.68 | 2.37 |
| Quick Ratio (TTM) | 0.68 | 2.37 |
| D/E Ratio (TTM) | 0.16 | 0.05 |
| Interest Coverage (TTM) | -6.27 | 226.81 |
| Piotroski F-Score | 4 | 7 |
| Altman Z-Score | N/A | 13.35 |
| LTL to 5YR AVG FCF | N/A | 0.53 |
| Shares Outstanding Growth 5YR AVG | N/A | -1.37% |